\
&
Contact us
Published on | 5 years ago
ProgrammesINNO4COV-19 OPEN CALL - Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance
Are you working for a company active in healthcare, medicine, biotech, biopharma, and/or IT-related topics (e.g. robotics, automation, electronics, nanotech, etc)? Then have a look at this accessible funding scheme (up to 100k€ subsidy).
Submission deadlines in November 2020, March 2021 and May 2021.
INNO4COV-19 at a Glance
Create a “lab-to-fab” platform and collaboration resource to enable companies and reference laboratories to develop and implement innovative technologies to fight COVID-19.
Website: www.inno4cov19.eu
The INNO4COV-19 Project aims to support the full development to market uptake of technologies at TRL6-7 or higher. It Provides funding to third parties to archive the desiderated objectives.
Eligibility criteria
What they offer
Key dates
The applications will be considered in three different rounds.
More information on the website of the call: www.inno4cov19.eu/open-call
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The European Holocaust Research Infrastructure Implementation Phase (EHRI-IP) project was funded under Horizon Europe call topic HORIZON-INFRA-2023-DEV-01-02. The project duration was two years and came to an end in February 2026. The main objective of the EHRI-IP project was to undertake all necessary legal, financial and strategic work to have a permanent organisation or ERIC (European Research Infrastructure Consortium) fully operational by the end of the implementation phase. The project consortium consisted of 14 partners from 13 countries. Read more about the project and the contribution of Flemish partner Kazerne Dossin in this testimonial.